AstraZeneca logo

AZN - AstraZeneca News Story

7943p -12.0  -0.2%

Last Trade - 23/10/20

Sector
Healthcare
Size
Large Cap
Market Cap £104.24bn
Enterprise Value £115.78bn
Revenue £19.71bn
Position in Universe 7th / 1805

BRIEF-AstraZeneca Says Imfinzi Showed Unprecedented Survival In Unresectable, Stage III Non-Small Cell Lung Cancer

Fri 18th September, 2020 8:05am
Sept 18 (Reuters) - AstraZeneca PLC  AZN.L :
    * ASTRAZENECA-IMFINZI SHOWED UNPRECEDENTED SURVIVAL IN
UNRESECTABLE, STAGE III NON-SMALL CELL LUNG CANCER WITH
ESTIMATED 50% OF PATIENTS SURVIVING 4 YRS

Source text for Eikon:  ID:nNDL7y5j8R 
Further company coverage:  AZN.L 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.